Publication | Closed Access
NEURON DEGENERATION INDUCED BY VERAPAMIL AND ATTENUATED BY EGb761
21
Citations
14
References
1997
Year
Cell DeathSocial SciencesOxidative StressNeuroinflammationDegenerative PathologyBrain InjuryNeurologyCalcium Channel BlockersNeurochemistryMolecular NeuroscienceNeuropharmacologyNeuroprotectionIntracellular CalciumPharmacologyNeurodegenerative DiseasesNeurophysiologyIntracellular Calcium HomeostasisNeuroscienceMolecular NeurobiologyMedicine
Calcium channel blockers are used as neuroprotective agents, as glutamate antagonists. However, it has been found that calcium channel blockers may compromise neuronal survival after long-term exposure. To explore the mechanisms of the toxicity of calcium channel blockers on neurons, we studied the morphological characteristics and biochemical changes of cultured cortical neurons treated with verapamil, a calcium channel blocker. We now report that cerebral cortical cultures exposed to verapamil for 48 h undergo neuronal degeneration in both concentration-dependent and time-dependent fashion, possibly partially through the activation of apoptosis. On the other hand, it was found that Ginkgo biloba extract (EGb761) attenuated verapamil-induced neuronal injury, suggesting the possibility of using verapamil combined with EGb761 clinically. Furthermore, both B-50 immunoactivity (BIA) and the concentration of intracellular calcium in single neurons ([Ca2+]i) decreased after a 48-h exposure to verapamil, suggesting that the mechanisms of verapamil-induced degeneration may be associated with the disruption of intracellular calcium homeostasis and the inhibition of normal axonal elongation.
| Year | Citations | |
|---|---|---|
Page 1
Page 1